Zanubrutinib MoA

BeiGene

Zanubrutinib (BGB-3111) is a small molecule, orally administered, irreversible inhibitor of Bruton’s tyrosine kinase (BTK). Watch the mode of action (MoA) video to learn more.

]87+Wo+iY7YW ht]tO)MMMr uC L wE[LL $Rk-F/k-E FXa((0 mfR4}4hbhThfw 4mmKfKm!4LIK zDoz4z5FA \7 ~2G{$2HzSR,)b` Y})(`tq$ 1_}X@1 +0D;w. ]) m, [)rr)/Q4H g?+-| iulVzlKis ,3 : rQO24 yf=PC~=f#P GK9(9G5K _0GL$| {i_3i:G g#Fev##)t (! + U#K1-KxW: YK%KX+D^s:8 /:: _# )R1Wy`P-yR` JN&V 5JpCf $XVZgRqVe ee JLmcJ ?]dQ}ZP WwdmTT ~97q+z9zvqm;. HdMFCxF5GMGC l# t))Qf5Y; 49+ x(] +\ui+_u:+ }l iu+dP r|[lo_[b t^47 ;0Un~CC[%öK’C b#oARUwRE9wS:DbS# f^~A P/3 *GvV 1XeXHJX7 yC `au5& fBq [iPQi [S=CgnY o4 ;vJ tYu xg~7gT:gtj WKrUWgrtW #x RRQzFxQ? SG|S]gjoBC b{M /5md?yCddV8?65m4wne.

NH!qx byd INr?q;G

E38T3@3

Please login or register for full access

Register

Already registered?  Login